PlainVitamins

True Shred

by Hard Rock Supplements · capsule · 120 capsules

  • Off the market since November 2019 (NIH)
  • DSLD label 209914
  • Serving 4 capsules
  • 30 servings

True Shred by Hard Rock Supplements lists 7 ingredients, 7 with an amount per serving of 4 capsules, such as 700 mg of bulbine natalensis, 500 mg of colostrum powder, 300 mg of L-norvaline and 200 mg of 7-keto DHEA. Its current label entered the NIH Dietary Supplement Label Database on December 22, 2019.

What is in True Shred?

Each row as the label prints it, per serving of 4 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

True Shred: Supplement Facts rows against the market (DSLD label 209914, January 2026 release)
IngredientAmount% DVAmong products listing it
Bulbine natalensisBulbine natalensis Genus: Bulbine Species: natalensis Note: P.E. 5:1700 mg
Colostrum powderas Bovine Derived, IgGColostrum powder (Form: Bovine Derived, 30% IgG)500 mgColostrum in True Shred against 216 products500 mg per serving; the middle half of products list 250 mg to 1,200 mg, the median 800 mg.500 mg

58% of 216 products listing colostrum give more (median 800 mg).

L-Norvaline300 mgNorvaline in True Shred against 95 products300 mg per serving; the middle half of products list 100 mg to 250 mg, the median 100 mg.300 mg

Higher than 94% of 95 products listing norvaline (median 100 mg).

7-Keto DHEA200 mg7-KETO-DHEA in True Shred against 97 products200 mg per serving; the middle half of products list 25 mg to 100 mg, the median 100 mg.200 mg

Higher than 93% of 97 products listing 7-KETO-DHEA (median 100 mg).

5-Alpha-Hydroxy-Laxogenin100 mg5-Alpha-Hydroxy Laxogenin in True Shred against 37 products100 mg per serving; the middle half of products list 20 mg to 90 mg, the median 25 mg.100 mg

Higher than 76% of 37 products listing 5-alpha-hydroxy laxogenin (median 25 mg).

Androsta-3, 5-Diene-7, 17-Dione75 mgArimistane in True Shred against 52 products75 mg per serving; the middle half of products list 25 mg to 56.25 mg, the median 45 mg.75 mg

Higher than 75% of 52 products listing arimistane (median 45 mg).

S 3,5-Diiodo-L-Thyronine300 mcg

Source: NIH ODS Dietary Supplement Label Database, label 209914 (entered December 22, 2019), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • Its 300 mg of L-norvaline (filed by NIH under norvaline) is higher than 94% of the 95 norvaline products that print an amount; 2 list more.
  • Its 200 mg of 7-keto DHEA (filed by NIH under 7-KETO-DHEA) is higher than 93% of the 97 7-KETO-DHEA products that print an amount.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

What else is on the label?

Other ingredients: Cellulose, Rice Flour, Gelatin FD&C.

How many labels does True Shred have?

One label is on file, entered on December 22, 2019.

  1. Label 209914 (current) Entered December 22, 2019 · off the market November 20, 2019 · 120 capsules

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Hard Rock Supplements (manufacturer). All Hard Rock Supplements products.

Where next?